169 related articles for article (PubMed ID: 34495053)
1. Evaluation of the American College of Radiology Thyroid Imaging, Reporting and Data System (Thyroid imaging reporting) scoring in thyroid Bethesda category on atypia and follicular lesion of uncertain significance patients.
Catal O; Ozer B; Sit M; Yazgi H
Rev Assoc Med Bras (1992); 2021 Apr; 67(4):511-515. PubMed ID: 34495053
[TBL] [Abstract][Full Text] [Related]
2. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
[TBL] [Abstract][Full Text] [Related]
3. Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications.
Babajani A; Rahmani S; Raoufi M; Eidgahi ES; Dastjerdi AV; Behfarnia P; Khalili S; Moghaddam NA
Front Endocrinol (Lausanne); 2023; 14():1135196. PubMed ID: 37313444
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAF
Lin Y; Luo YK; Li J; Ren XY; Wang HW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
[TBL] [Abstract][Full Text] [Related]
5. The impact of thyroid imaging reporting and data system on the management of Bethesda III thyroid nodules.
Alqahtani SM; Al-Sobhi SS; Alturiqy MA; Alsalloum RI; Al-Hindi HN
J Taibah Univ Med Sci; 2023 Jun; 18(3):506-511. PubMed ID: 36818179
[TBL] [Abstract][Full Text] [Related]
6. Use of the thyroid imaging, reporting, and data system (TI-RADS) scoring system for the evaluation of subcentimeter thyroid nodules.
Weiss VL; Andreotti RF; Ely KA
Cancer Cytopathol; 2018 Aug; 126(8):518-524. PubMed ID: 29733503
[TBL] [Abstract][Full Text] [Related]
7. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
[TBL] [Abstract][Full Text] [Related]
8. Does the ACR TI-RADS scoring allow us to safely avoid unnecessary thyroid biopsy? single center analysis in a large cohort.
Koseoglu Atilla FD; Ozgen Saydam B; Erarslan NA; Diniz Unlu AG; Yilmaz Yasar H; Ozer M; Akinci B
Endocrine; 2018 Sep; 61(3):398-402. PubMed ID: 29744655
[TBL] [Abstract][Full Text] [Related]
9. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
[TBL] [Abstract][Full Text] [Related]
10. USING THE ATA AND ACR TI-RADS SONOGRAPHIC CLASSIFICATIONS AS ADJUNCTIVE PREDICTORS OF MALIGNANCY FOR INDETERMINATE THYROID NODULES.
Ahmadi S; Herbst R; Oyekunle T; Jiang X'; Strickland K; Roman S; Sosa JA
Endocr Pract; 2019 Sep; 25(9):908-917. PubMed ID: 31170369
[No Abstract] [Full Text] [Related]
11. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
12. Factors Predicting Thyroid Malignancy in Fine Needle Aspiration Biopsy Specimens Classified as Atypia of Uncertain Significance/Follicular Lesion of Uncertain Significance.
Brown C; Mangano W; Thompson S; Richmond B
Am Surg; 2018 Jul; 84(7):1207-1213. PubMed ID: 30064590
[TBL] [Abstract][Full Text] [Related]
13. Strategy to reduce unnecessary surgeries in thyroid nodules with cytology of Bethesda category III (AUS/FLUS): a retrospective analysis of 667 patients diagnosed by surgery.
Suh YJ; Choi YJ
Endocrine; 2020 Sep; 69(3):578-586. PubMed ID: 32297204
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Malignant Thyroid Nodules That Do Not Meet ACR TI-RADS Criteria for Fine-Needle Aspiration.
Middleton WD; Teefey SA; Tessler FN; Hoang JK; Reading CC; Langer JE; Beland MD; Szabunio MM; Desser TS
AJR Am J Roentgenol; 2021 Feb; 216(2):471-478. PubMed ID: 32603228
[No Abstract] [Full Text] [Related]
15. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.
Kim SJ; Roh J; Baek JH; Hong SJ; Shong YK; Kim WB; Song DE
Cytopathology; 2017 Feb; 28(1):65-73. PubMed ID: 27245883
[TBL] [Abstract][Full Text] [Related]
16. Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory.
Rosario PW
Thyroid; 2014 Jul; 24(7):1115-20. PubMed ID: 24684285
[TBL] [Abstract][Full Text] [Related]
17. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
Hyeon J; Ahn S; Shin JH; Oh YL
Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of ACR TI-RADS cytologically indeterminate thyroid nodules and molecular profiles: a single-institutional experience.
Belovarac B; Zhou F; Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Szeto O; Simsir A; Sheth S; Brandler TC
J Am Soc Cytopathol; 2022; 11(3):165-172. PubMed ID: 35181254
[TBL] [Abstract][Full Text] [Related]
19. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY
Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631
[TBL] [Abstract][Full Text] [Related]
20. Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS).
Yoon JH; Kwon HJ; Kim EK; Moon HJ; Kwak JY
Clin Endocrinol (Oxf); 2016 Aug; 85(2):275-82. PubMed ID: 26639612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
